drugset / Trial / NCT02209649
Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study to compare the bioavailability of Lacidipine and Telmisartan administered as fixed dose combination tablets with the separate Telmisartan and Lacidipine tablets.
Timeline
- Start
- 1999-10
- Primary completion
- 1999-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lacidipine | Small molecule | 4 mg | Oral |
| Comparator | Telmisartan | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.